Newell Sleep SRL
Newell Sleep reported total assets of 271,670 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026).
The score of Newell Sleep shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +452 % Total assets +518 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Newell Sleep's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 200,824 € | ||||
| Equity | 196,805 € | ||||
| Cash | 171,853 € | ||||
| EBITDA | 266,180 € | ||||
| Total assets | 271,670 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 19 Jun 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
Newell Sleep's financial analysis
- Solvency72.4%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Newell Sleep
Newell Sleep's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0746.760.933
- VAT number
- BE0746760933
- Peppol
- Registered · 0208:0746760933 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 May 2020
- Registered office
- 1380 Lasne
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Newell Sleep (SRL) has been based in Lasne since 2020, active in: medical specialists activities. For 2025, it reports a net profit of 200,824 € and equity of 196,805 €; its revenue is not published. Its solvency stands at 72.4%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Newell Sleep
Companies in the same business, of comparable size and area, outside its group.
- Cabinet Medical Docteur Sophie Galetic Medical specialists activities Visé · balance sheet 271,224 €
- Docteur Karole KOSTYLA Medical specialists activities Nivelles · balance sheet 270,632 €
- Antales Medical specialists activities Éghezée · balance sheet 272,773 €
- Med Anesth Medical specialists activities Wezembeek-Oppem · balance sheet 273,003 €
- Medicale Costalunga Serge Medical specialists activities Liège · balance sheet 273,038 €
- Derma DR Croquet Medical specialists activities Charleroi · balance sheet 271,708 €
- Dr. Leen de Backer , Medische Oncologie Medical specialists activities Aalter · balance sheet 271,731 €
- Lungami Medical specialists activities Woluwe-Saint-Lambert · balance sheet 271,869 €
Frequently asked questions about Newell Sleep
What is the revenue of Newell Sleep?
Newell Sleep files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Newell Sleep?
In Belgium, the VAT number is the company number prefixed with BE: BE0746760933 for Newell Sleep, if the company is VAT-registered. Its company number (CBE) is 0746.760.933.
Where is the registered office of Newell Sleep?
According to the CBE register, the registered office of Newell Sleep is in 1380 Lasne.
What is the equity of Newell Sleep?
At the close of the 2025 financial year, the equity of Newell Sleep amounts to 196,805 €, a solvency of 72.4% of total assets.
Who manages Newell Sleep?
The register lists 1 active mandates at Newell Sleep. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Newell Sleep
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →